PhaseBio Pharmaceuticals, Inc. (PHAS)
SBC to Revenue
343.75%
Quarterly · Period ending:
PHAS SBC to Revenue
Latest reported343.75%period ending
Latest reported343.75%period ending
PHAS Quarterly SBC/Revenue (0.00% → 343.75%)
Latest values, visible window
High-resolution chart · PNG
PHAS sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 343.75% | |
| 510.2564% | |
| 94.9367% | |
| 214.9254% | |
| 7.042% | |
| 0% | |
| 181,875,000,000,000% | |
| 252.6971% | |
| 81.7923% | |
| 147.1875% | |
| 55.2356% | |
| 203.7344% | |
| 38.4068% | |
| 36.4472% | |
| 27.2374% | |
| 23.3577% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |